BioInformant

Your Global Leader in Stem Cell Market Research

Home » direct cell reprogramming

Direct Cell Reprogramming: What Is It and How Does It Work?

By 6 Comments

There has been tremendous activity over the last decade in the development of stem cells therapeutics, which have relied on stem cell differentiation protocols, as well as techniques for direct cell reprogramming. Today, there are over 5,400 stem cell trials registered on ClinicalTrials.gov and publications have increased dramatically in recent years, demonstrating the rapidly growing interest of the scientific community.

However, for all its promise, stem cells are yet to deliver on this therapeutic potential, and this failure appears due to various technical challenges that still need to be overcome. [Read more…]

The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy

By 4 Comments

What do we know of the safety and efficacy of stem cell therapeutics? Over 50 years have passed since the discovery of hematopoietic stem cells (bone marrow transplantation to cure diseases such as leukemia), over 20 years since the discovery of human embryonic stem cells (hESC), and 15 years since the discovery of induced pluripotent stem cells (iPS cells). There are now thousands of stem cell trials underway in clinics worldwide.

Despite this experience, what do we actually know about the safety and efficacy of stem cell therapeutics? [Read more…]

Mogrify Raises $3.7M for Direct Cell Reprogramming and Appoints Dr. Disley CEO

By Leave a Comment

MogrifyMogrify (Cell Mogrify Ltd) is a private biotechnology company has developed a direct cellular conversion technology to allow for the transformation (transmogrification) of any mature human cell type into any other – without going through a pluripotent stem cell- or progenitor cell-state. [Read more…]

BioInformant's World-Class Clients